TWI627940B - Physiological parameter monitoring system - Google Patents

Abstract

The invention provides a physiological parameter monitoring system, comprising a first detecting device, a second detecting device and a server. The first detection device is adapted for personal use and generates a plurality of first physiological parameter information relating to the user. The second detection device is adapted for use by a medical professional and generates a second physiological parameter information relating to the user. The server connects the first detecting device and the second detecting device through a network, and receives the first physiological parameter information and the second physiological parameter information from the first detecting device and the second detecting device respectively, All physiological parameter information is integrated on the server for data management analysis. The invention also provides a corresponding application software for the user to access the analysis data through the terminal device.

Description

Physiological parameter monitoring system

The invention relates to a physiological parameter monitoring system, in particular to a first physiological parameter information which can be integrated by a detecting device for self-detection, and a second physiological parameter information detected by a detecting device used by a medical professional. Physiological parameter monitoring system.

In addition to blood glucose management, glycated hemoglobin is also an important indicator of glycemic control in diabetic patients. Existing blood glucose machines for self-monitoring of blood glucose allow diabetic patients to easily self-detect blood glucose levels before or after a meal, but in general, they cannot detect glycosylated hemoglobin in diabetic patients. Diabetic patients need to go to a medical institution and use a blood glucose machine for medical professionals, such as the existing Point-of-Care Testing (POCT) or a large biochemical analyzer to detect glycated hemoglobin; therefore, It is quite inconvenient for diabetic patients who need to track glycated hemoglobin regularly.

In addition, although diabetic patients can use the above-mentioned blood glucose meter for self-glycemic detection to detect blood sugar levels, in the absence of a management mechanism for the detected blood sugar level, it is difficult for diabetic patients to record and observe changes in their own blood glucose levels.

Accordingly, it is an object of the present invention to provide a physiological parameter monitoring system that facilitates periodic tracking of glycated hemoglobin values and blood glucose levels by a user.

Therefore, the physiological parameter monitoring system of the present invention comprises a first detecting device, a second detecting device, and a server.

The first detection device is adapted for personal use and produces a plurality of blood glucose values associated with a user.

The second detection device is adapted for use by a medical professional or medical care and produces a glycated hemoglobin measurement associated with the user.

The server connects the first detecting device and the second detecting device through a network, and receives the blood sugar level and the glycated hemoglobin measurement value from the first detecting device and the second detecting device respectively, and according to the The glycemic value estimates a glycosylated hemoglobin estimate and outputs the glycated hemoglobin measurement and the glycated hemoglobin estimate.

The invention has the advantages of providing statistical analysis and management of blood sugar levels, and facilitating users to regularly track glycated hemoglobin values and blood sugar levels.

Referring to FIG. 1 , an embodiment of the physiological parameter monitoring system 1 of the present invention includes a first detecting device 22 , a first server 13 , and a second server 3 located in the medical institution, at least one workstation terminal 14 and a Second detecting device 12. The at least one workstation terminal 14 is connected to the second server 3, and can be connected to the Internet through the second server 3. The Health Information System (not shown in FIG. 1) of the medical institution is also The second server 3 can be connected. In one embodiment, the second server 3 can include the hospital management system. In one embodiment, the physiological parameter monitoring system 1 optionally includes an insurer or health service provider server 6 or/and other authorization devices 7, wherein the first detection device 22 and the second detection device 12 may be a detecting device for monitoring physiological parameters or detecting disease, health, nutritional intake, fitness condition or exercise condition, the first server 13, the first detecting device 22, the workstation terminal 14 and the second detecting device 12 All data can be transmitted through the network, and each corresponding application software can be run to collect and analyze the measurement data. The application software may be built in the device or obtained from the outside, such as a network download, a cloud software accessed through a webpage, etc., but is not limited thereto.

A first application software (not shown in FIG. 1) used by the individual running on the first detecting device 22 can transmit the measurement data to the first server 13, selectively performing a more complicated analysis operation, and The measurement data is transmitted back to the first application software, and the data is transmitted by the first server 13 to the second server 3 after being authorized by the user, so that the medical staff can pass through the workstation terminal 14 Accessing a professionally used second application software (not shown in FIG. 1) provided by the second server 3 and for performing diagnosis based on the measurement data. In addition, after the measurement data generated by the second detecting device 12 is transmitted to the second server 3 or the first server 13, the data is also transmitted to the first application software and the second application software. In another embodiment, the data measured by the first detecting device 22 and the second detecting device 12 are also transmitted to the hospital management system located in the medical institution for storage as medical record data. On the other hand, when the medical staff operates the second application software to add a patient, an operator, or other items, the updated item can be transmitted to the second detecting device 12 through the second server 3. The end management software (not shown in FIG. 1) allows the second detecting device 12 to set an operator or a measured object according to a doctor's order or a work order.

As shown in FIG. 1, the first detecting device 22 includes a blood glucose detecting unit 11 and a mobile device 2. In another embodiment (not shown in FIG. 1), the first detecting device 22 can be a mobile device having a blood glucose measuring function, and the measuring function can measure blood glucose through a built-in or externally connected mobile device. The module is implemented, so that it is not necessary to provide an independent blood glucose detecting unit, wherein the blood glucose measuring module can be externally connected to the mobile device through a hole such as a USB, an audio hole, a Bluetooth, or an infrared. In another embodiment (not shown in FIG. 1), the first detecting device 22 can be the blood glucose detecting unit 11 having a network transmission function, and the transmitting function can be built-in or externally connected to the first detecting. A transmission module of device 22 is implemented such that the blood glucose detecting unit 11 can include the functions required by both the blood glucose meter and the mobile device. Hereinafter, the first detecting device 22 includes an embodiment in which the blood glucose detecting unit 11 and the mobile device 2 are included, wherein the first application software is installed in the mobile device 2.

The blood sugar detecting unit 11 is a blood glucose meter for self-blood glucose detection, which is used for allowing a user to measure his or her blood sugar level before, after, after, after, after going to bed, or at other times, and communicating through a wireless or wired network. For example, a data sequence formed by the data corresponding to the blood glucose level and the blood glucose level is transmitted to the mobile device 2, where the data sequence may include: an event tag, a record number, a measurement time, Measurement time corresponding to Coordinated Universal Time (UTC), measurement date, measurement time zone, blood glucose meter model, blood glucose meter serial number, user account number, whether it is the quality of the quality control fluid, whether the measured temperature exceeds the standard, and the data Type (generated by the first detecting device or the second detecting device, or manually input), etc., wherein according to the type of the data, it can be determined from which medical institution the blood glucose value comes from, and the dispute over the use of personal data in the future is avoided, and the mobile device 2 can be a smart phone, a wearable device or a tablet. In one embodiment, the user can operate the mobile device 2 to manually input the measured blood glucose value and the corresponding data directly to the mobile device 2. The first application software allows the user to delete the manually entered blood glucose level in order to prevent the input of the blood glucose from being input incorrectly.

On the other hand, since the user may not be automatically adjusted according to the time zone of the user's location because the user may travel abroad or negotiate, the user must manually adjust the blood glucose value according to the measurement time. There will be troubles in different time zones, and there will be inaccuracies when performing blood glucose analysis. The physiological parameter monitoring system 1 provides the following solutions to deal with the problems encountered above. Referring to FIG. 2, first, in step S21, the blood glucose detecting unit 11 and the mobile device 2 are connected via a wireless or wired network. Next, in step S22, the mobile device 2 transmits the local time on the mobile device 2 to the blood glucose detecting unit 11 to set the clock of the blood glucose detecting unit 11 so that the time of the blood glucose detecting unit 11 can be combined with the mobile device 2 Synchronization is maintained, so that the problem of manually adjusting the time of the blood glucose detecting unit 11 when the user moves to a different time zone can be avoided. Next, in step S23, the blood glucose detecting unit 11 transmits the blood glucose value and the data sequence to the first application software of the mobile device 2, wherein the measurement time in the data sequence is local time, according to different Events, such as eating, exercising, medication, etc. Next, in step S24, the first application software converts the measurement time into a UTC time storage in addition to storing the data sequence including the measurement time, so that the blood glucose value can be sorted according to the UTC time, avoiding according to the When the measurement time (local time) is sorted by blood glucose values, the problem of the true order cannot be presented, wherein the UTC time is only used for sorting blood glucose values, and can be selectively displayed on the first application software.

For example, referring to FIG. 3, when the user or medical staff operates the mobile device 2 or the workstation terminal 14 to execute the first application software or the second application software, the mobile device 2 or the workstation terminal 14 The plurality of blood glucose values displayed on the display screen are sorted according to their respective measured UTC times, and the top is the latest blood glucose data based on the measured UTC time, sequentially arranged downward, however, the display The screen displays the measurement time (local time) T corresponding to each blood glucose level, which is convenient for the user to view the blood glucose record. Therefore, the measurement time (local time) will be earlier than the blood glucose level 31 in the measurement time (local time). The situation before the blood sugar level of 32 is later. In one embodiment, when the pen blood glucose value is transmitted to the mobile device 2, the mobile device 2 estimates the measurement region where the blood glucose level is located according to the longitude and latitude of the mobile device, and displays the corresponding blood glucose value. Country, the country can be displayed in the time zone, national flag, country name or a combination thereof. On the other hand, referring to FIG. 4, the first application software and the second application software may also pair the blood glucose values according to the measurement time (local time) T before and after the occurrence of events such as eating, exercising, and medication. To form a pairing combination 41, as shown in FIG. 4, the pairing combination 41 is a pairing of two blood glucose values before and after lunch.

In addition, in an embodiment, after the user operates the mobile device 2 to transmit the blood glucose value to the first server 13 through the Internet, the medical institution can initiate the medical institution when all the medical requirements are required. A request is made to request the user to authorize the medical institution to use the measurement data transmitted to the first server 13. Referring to FIG. 5, first, in step S51, the medical staff accesses the second application software provided by the second server 3 through the working terminal 14 to issue an authorization request to the first server 13. Next, in step S52, the first server 13 transmits the authorization code to the mobile device 2 through the short message, but is not limited thereto, and may be other authorization methods. At step S53, the user can decide whether or not they are willing to authorize the personal measurement data used by the hospital. If the user is willing to authorize, in step S54, the user provides the authorization code to the medical staff, and the medical staff operates the workstation terminal 14 to input the authorization code provided by the user to the second server located in the medical institution. 3 second application software provided. At step S55, the second server 3 located at the medical institution verifies the authorization code received at step S54 to the first server 13. In step S56, when the first server 13 notifies the second server 3 to pass the verification, in step S57, the medical institution can obtain the user authorized use of personal data and test data, if used in step S53, The user does not agree with the authorization, or in step S56, when the verification fails, the medical institution cannot obtain the authorization of the user, and thus the personal measurement data of the user cannot be used. In addition to transmitting the authorization code through the short message, in another embodiment, the first server 13 can send a notification message to the mobile device 2 for the user to select whether to approve the authorization. In an embodiment, the mobile device 2 may list the object to be authorized, and let the user select the object of consenting to the authorization, wherein the object is not limited to the medical institution, and may be an insurance company, a pharmacy, or another health service provider. 6, but not limited to this. The physiological parameter monitoring system 1 can effectively protect the privacy of the user's personal medical information by means of user authorization. On the other hand, when the user wants to quit the service provided by the system, the first application software can be operated to transmit a delete command to the first server 13, and the user is deleted and transmitted to the first server. The first server 13 transmits a notification message to the second server 3 to notify the authorized medical institution to delete the data transmitted by the user to the second server 3.

The second detecting device 12 is a blood glucose meter for medical professionals, such as the existing key care detector Righttest ^® GM700 Pro or/and other biochemical analyzers, which are suitable for setting in the medical institution and managed by the back end. The software manages the functions of quality management, group management, analysis of chart output, connection to the hospital order system, and the like, and can be connected to the second server 3 located in the medical institution. When the user visits the medical institution, the second detecting device 12 measures the glycated hemoglobin measurement value and the blood sugar level of the user, and measures the glycated hemoglobin through the second server 3. The value and the blood glucose value are transmitted to the first server 13, wherein the second detecting device 12 transmits the measurement through the second server 3 because the user has authorized the measurement data of the individual used by the medical institution. The user's authorization is not required when the data is sent to the first server 13. In another embodiment, the medical staff manually inputs to the second application software from the workstation terminal 14 of each department to transmit the glycated hemoglobin measurement value to the first server via the network through the second server 3. 13. In an embodiment, the second detecting device 12 is directly connected to the first server 13 through a network, so that the data measured by the user in the medical institution through the second detecting device 12 can be used by the second detecting device. 12 is directly uploaded to the first server 13, wherein the workstation terminal 14 may be an arithmetic device such as a desktop computer, a notebook computer, a tablet computer, a smart phone, etc., but is not limited thereto.

The first server 13 or the second server 3 estimates a glycated hemoglobin based on a plurality of blood glucose values measured by the user using the blood glucose detecting unit 11 or the second detecting device 12 in a time interval. Estimating the value (Est. HbA1c), and outputting the glycated hemoglobin measurement value and the glycated hemoglobin estimation value to the first application software of the mobile device 2 and the second application software provided by the second server 3; In addition to allowing the user to see the measured amount of glycated hemoglobin measured at the medical institution through the mobile device 2, the glycated hemoglobin measurement can also be traced by observing the glycated hemoglobin estimate, and the same After being authorized by the user, the medical staff can also view and analyze all the values measured by the user through the blood glucose detecting unit 11 and the second detecting device 12 through the workstation terminal 14, so that the comprehensive evaluation can be performed. The health of the user. In the above embodiment, if glycated hemoglobin is an important key indicator in terms of blood glucose control, in other embodiments, different indicator substances may be replaced or added to comprehensively evaluate the user's health condition.

In this embodiment, the first server 13 calculates an average value of the blood glucose values in the time interval, and calculates the glycated hemoglobin estimation value based on the average value, that is, the glycated hemoglobin estimation value= (blood glucose average + first parameter) / second parameter, preferably, the first parameter is a value between 43 and 48, and the second parameter is a value between 25 and 30.

For example, referring to FIG. 6, FIG. 6 illustrates the saccharification seen by the user operating the mobile device 2 or the medical staff operating the workstation terminal 14 after running the corresponding application software at the mobile device 2 or the workstation terminal 14. The hemoglobin measurement value, the blood glucose level measured by the blood sugar detecting unit 11 or the second detecting device 12, and the glycated hemoglobin estimated value (Est. HbA1c) and the like. The user visits the medical institution every three months and measures the glycated hemoglobin measurement by using the second detecting device 12 at the medical institution at 2016/1/1 and 2016/4/1, respectively. The values are 6.6% and 6.3%. When the medical staff selects one of the fields of glycosylated hemoglobin measurement, the application software will display the measurement time of the glycated hemoglobin measurement value and push the self-quantity within a certain interval. Measure blood glucose levels, such as all blood glucose values for 90 days. For example, when you select the field for the measured glycated hemoglobin measurement measured in 2016/1/1, the list of blood glucose values on the right will display 2016/1/ 1 Push forward all blood glucose values for 90 days for medical staff to use as an auxiliary reference tool for diagnosing the glycated hemoglobin measurement. The application software calculates the corresponding glycated hemoglobin estimation value based on all the blood glucose values measured by the blood glucose detecting unit 11 or the second detecting device 12 during the seven days for the seven-day period.

As shown in FIG. 6 , the user commonly used the blood glucose detecting unit 11 or the second detecting device 12 to measure the blood glucose level 15 times during the period from 2016/4/1 to 2016/4/7, and in 2016/4. The blood glucose detecting unit 11 or the second detecting device 12 collectively measured the blood glucose level 32 times during the period from 8/2016 to 4/14; and the first server 13 estimates the saccharification based on the 15 blood glucose levels. The estimated hemoglobin was 6.1%, and the estimated glycated hemoglobin based on the 32 blood glucose values was 5.7%. It can be seen from the above that although the user measures the glycated hemoglobin measurement value in the medical institution every three months, the user can conveniently observe the weekly by the physiological parameter monitoring system 1 of the present invention. The glycated hemoglobin estimate is used to track the change of the glycated hemoglobin. When the difference between the estimated glycated hemoglobin and the glycated hemoglobin measurement exceeds a threshold, the first application software or the second application software can also output a warning message. When the user finds abnormal changes in glycated hemoglobin, he can immediately seek medical treatment, wherein the threshold value can be a value between 1.5% and 3%; and even if there is no abnormal change in glycated hemoglobin, the glycated hemoglobin estimates It can also be consulted by doctors when you seek medical attention. On the other hand, in one embodiment, the first detecting device 22 estimates the glycated hemoglobin estimation value via the first application software on the mobile device 2 using the blood glucose level measured by the blood glucose detecting unit 11 without By performing the calculation by the first server 13, the change of the glycated hemoglobin can be traced by itself. In addition, the time interval is not limited to seven days, but may be 14 days, 30 days, or other days.

In addition to the estimation and management of glycated hemoglobin, the physiological parameter monitoring system 1 of the present invention further provides statistical analysis and management of blood glucose levels. In detail, the first server 13 calculates one of the blood glucose levels in the time interval based on the blood glucose values received from the blood glucose detecting unit 11 or the second detecting device 12 during the time interval. The average is one standard deviation. When the standard deviation is greater than a first multiple of the average value, the first server 13 further outputs a message for indicating "fluctuation is too large"; when the standard deviation is less than a second multiple of the average value, the The first server 13 also outputs a message for indicating "fluctuation ideal"; and when the standard deviation is greater than the second multiple of the average value and less than the first multiple of the average value, the first server 13 And outputting a message for indicating "large fluctuation"; wherein the first multiple is greater than the second multiple, and preferably, a value between 0.2 and 1 and a value between 0.1 and 0.7, respectively. Or preferably, a value between 0.3 and 0.6 and a value between 0.2 and 0.4, respectively.

For example, referring to FIGS. 7-9, the user operates the mobile device 2, the workstation terminal 14 operated by the medical staff, or the authorized authorization device 7 in the physiological parameter monitoring system 1 to connect the first servo. The management information related to the blood glucose level displayed on the screen of the terminal or device after running the corresponding application software; in particular, the straight bar graph 4 and the message block 5 including the horizontal bar graph 51 To display statistical analysis results.

For example, as shown in FIG. 7, the bar graph corresponding to the blood glucose level measured by the user after the breakfast meal during the period of 2016/4/23~2016/4/29 shows that the average blood glucose level is 197 mg/ dL and the standard deviation is 51.6, wherein the height of the bar graph corresponds to the average value of blood glucose, and the height of the portion with color filling in the bar graph corresponds to the standard deviation; in particular, because 51.6 is less than the second multiple of 197, Therefore, in the bar graph, the height of the green portion (indicated by the dot plot) is expressed as 51.6 to indicate that the fluctuation of the blood glucose level is ideal. The long bar graph corresponding to the blood glucose level measured by the user after the lunch meal during the period of 2016/4/16~2016/4/22 shows that the average blood glucose level is 193 mg/dL and the standard deviation is 80.5; The second multiple of 193 is less than the first multiple of 193, so 80.5 is indicated by the height of the orange portion (indicated by the L-shaped diagram) in the bar graph to indicate that the fluctuation of the blood glucose level is large. In addition, although not shown in FIG. 7, if the fluctuation of the blood glucose level is too large, the standard deviation of the first multiple of the average value is represented by red in the bar graph; and although it is respectively green, orange, Red indicates that the fluctuation of blood sugar value is ideal, the fluctuation of blood sugar level is large, and the fluctuation of blood sugar level is too large, but it is not limited to this. The choice of color, appearance or design can be distinguished by the above three fluctuations. It can also be adjusted to calculate by week/month/year/or other days during the calculation of the fluctuations.

Referring to FIG. 8 and FIG. 9, when the user operates the corresponding application software of the workstation terminal 14 through the mobile device 2 or the medical staff, and selects the straight bar graph 4, the application software further displays a blood glucose pen. Message block 5 of information such as number, fluctuation, and horizontal bar graph 51. Specifically, the two ends of the horizontal bar graph 51 respectively display the lowest value, the highest value, and the average value of the corresponding blood sugar level; wherein the red portion of the horizontal bar graph 51 is represented by a + type diagram ) The number of pens that represent too high a blood sugar level accounts for the proportion of all blood glucose pens, the gray part represents the normal number of blood glucose values, and the blue part (represented by a Δ-type graph) The number of pens with low blood sugar levels accounts for the proportion of all blood glucose pens.

For example, as shown in FIG. 8, when the user operates the corresponding application software of the workstation terminal 14 through the mobile device 2 or the medical staff member and selects the straight bar graph 4a, the displayed message block 5 It shows that there are seven blood glucose values after breakfast meal in 2016/4/23~2016/4/29. The lowest, highest and average values of these blood glucose values are 111, 272 and 197 mg/dL, respectively. And although the fluctuation of these blood glucose values is ideal, there are still some cases where the blood glucose level is too high, indicating that it is ideal for fluctuations in the case where most blood glucose levels are too high. As shown in Figure 9, when the user or medical staff clicks on the straight bar graph 4b, the displayed message box 5 indicates the lunch after the 2016/4/23~2016/4/29 period. There are 3 blood glucose levels. The lowest, highest and average values of these blood glucose values are 89, 114 and 102 mg/dL, respectively. Although the fluctuation of these blood glucose values is ideal, some blood glucose values are still too low. It shows that it is ideal for fluctuations in most cases where the blood glucose level is low. Therefore, the physiological parameter monitoring system 1 jumps out of the message box 5 to display the blood glucose fluctuation and other statistical analysis results, which can provide the user with simple and rapid monitoring of the blood sugar trend, early Prevent the disease from getting worse.

Referring to FIG. 10, it shows the blood glucose management information accumulated by a user after using the physiological parameter monitoring system. Through the use of the physiological parameter monitoring system of the present invention, the user measures information analysis technology and visualizes the chart. The doctor can easily identify the patient's blood glucose management status, and can assist the doctor to make an effective diagnosis, as shown in Figure 10. The bottom to the top shows the older to newer data, from which it can be observed that the user uses the physiological parameters. After the monitoring system performs the diagnosis, with the aid of the effective tool, the straight bar graphs 4c and 4d displayed from the red (indicated by the +-type graph) indicating the blood glucose value "over-fluctuation" slowly progress toward the blood glucose over time. The green value of the "fluctuation ideal" progresses (indicated by a dot plot), so the physiological parameter monitoring system presents the blood glucose values in a paired combination, and compares the measured glycated hemoglobin measurement with the estimated value as a diagnosis. Reference, and a graph of the mean and standard deviation calculated by blood glucose values to present fluctuations in blood glucose, providing a means to assist the user in effectively controlling blood The method of sugar.

In summary, the physiological parameter monitoring system of the present invention generates a blood glucose level related to a user by the blood glucose detecting unit, and the second detecting device generates a glycated hemoglobin measurement value and a blood sugar level related to the user, the first The server or the second server estimates the glycated hemoglobin estimation value according to the blood sugar level, and outputs the glycated hemoglobin measurement value, the glycated hemoglobin estimation value, and the blood sugar level to the mobile device, and further provides statistical analysis and management of the blood glucose value, and can It is convenient for the user to regularly track changes in the glycated hemoglobin value and the blood sugar level, so that the object of the present invention can be achieved.

However, the above is only the embodiment of the present invention, and the scope of the invention is not limited thereto, and all the simple equivalent changes and modifications according to the scope of the patent application and the patent specification of the present invention are still Within the scope of the invention patent.

1‧‧‧ Physiological parameter monitoring system
11‧‧‧ Blood glucose testing unit
12‧‧‧Second detection device
13‧‧‧First server
14‧‧‧Workstation terminal
2‧‧‧Mobile devices
22‧‧‧First detection device
3‧‧‧Second server
4‧‧‧ Straight bar chart
4a~4d‧‧‧ Straight bar chart
5‧‧‧ message box
51‧‧‧ horizontal bar chart
6‧‧‧Server
7‧‧‧Authorized device

Other features and advantages of the present invention will be apparent from the embodiments of the present invention, wherein: FIG. 1 is a schematic diagram illustrating an embodiment of the physiological parameter monitoring system of the present invention; FIG. 2 is a flow chart illustrating A blood glucose detecting unit transmits a blood glucose level and a corresponding data sequence to a mobile device; FIG. 3 is a display screen showing the plurality of sorted blood glucose levels; FIG. 4 is a display screen displaying multiple blood glucose levels Figure 5 is a flow chart illustrating the steps taken by the medical institution to obtain authorization from the first detecting device; Figure 6 is a schematic view showing the display of blood sugar level, glycated hemoglobin measurement value, glycated hemoglobin on a mobile device Figure 7 is a schematic diagram showing a plurality of straight bar graphs showing blood glucose levels on the mobile device; FIG. 8 is a schematic diagram showing a message block displaying blood glucose values on the mobile device; 9 is a schematic diagram illustrating another message block for displaying a blood glucose level on the mobile device; and FIG. 10 is a schematic diagram showing a plurality of sets of blood glucose values after sorting

Claims (13)

A physiological parameter monitoring system comprising: a first detecting device adapted for personal use and generating a plurality of first physiological parameters related to a user; a second detecting device adapted for use by a medical professional and generating a second physiological parameter related to the user; and a first server, connecting the first detecting device and the second detecting device through a network, and receiving respectively from the first detecting device and the second detecting device The first physiological parameter and the second physiological parameter, wherein the first physiological parameter and the second physiological parameter are related to a state or condition of the user's disease, health, nutritional intake, fitness or exercise. The physiological parameter monitoring system of claim 1, wherein each first physiological parameter is a blood glucose level, and the second physiological parameter is a glycated hemoglobin measurement. The physiological parameter monitoring system according to claim 2, wherein the first server estimates a glycated hemoglobin estimation value based on the blood glucose levels, and outputs the glycated hemoglobin measurement value and the glycated hemoglobin estimation value. The physiological parameter monitoring system of claim 1, further comprising a second server, wherein the second server is disposed in the medical institution, and the second server executes a function for obtaining authorization from the first detecting device The method includes the following steps: (a) the second server sends an authorization request to the first server; (b) the first server sends an authorization message to the first detecting device; (c) The second server receives the authorization message via an input of a user associated with the first detecting device; (d) the second server verifies the authorization message to the first server; and (e) When the verification result of the step (d) is affirmative, the second server obtains the authorization. The physiological parameter monitoring system of claim 4, wherein in the step (b), the authorization message is an authorization code or an authorization notification. The physiological parameter monitoring system of claim 4, wherein in the step (b), the first server transmits the authorization message via the network. The physiological parameter monitoring system according to claim 3, wherein the first server calculates an average value of the blood glucose levels, and calculates the glycated hemoglobin estimation value according to the average value, wherein the glycated hemoglobin estimation value is positive Related to this average. The physiological parameter monitoring system according to claim 3, wherein the first server outputs a warning message when the difference between the glycated hemoglobin measurement value and the glycated hemoglobin estimation value is greater than a threshold value. The physiological parameter monitoring system of claim 2, wherein the second detecting device further generates a blood glucose value associated with the user and transmits the blood glucose value to the first server, and the first server further At least one statistic is calculated based on a plurality of the blood glucose values received from the first detecting device and the second detecting device. The physiological parameter monitoring system of claim 9, wherein the first server calculates one of the plurality of blood glucose values according to the plurality of blood glucose values received from the first detecting device and the second detecting device The average value is a standard deviation. When the standard deviation is greater than a first multiple of the average value, the first server further outputs a message for indicating excessive fluctuation, when the standard deviation is less than a second of the average value. When the multiple is used, the first server further outputs a message for indicating the ideal of the fluctuation. When the standard deviation is greater than the second multiple of the average value and less than the first multiple of the average value, the first server further Outputting a message for indicating a large fluctuation, wherein the first multiple is greater than the second multiple. The physiological parameter monitoring system of claim 10, wherein the system provides a visualization chart having a horizontal axis for indicating a plurality of event labels of the blood glucose level, and a vertical axis for indicating the average value and the standard deviation a value, a plurality of average indicators, and a plurality of standard deviation indicators, wherein the plurality of average indicators indicate a value of the average, the plurality of standard deviation indicators indicating a value of the standard deviation, the standard deviation indication At least a portion of the device is located within the average indicator. The physiological parameter monitoring system of claim 1, wherein the first detecting device comprises a detecting unit and a mobile device, the detecting unit generates the first physiological parameters, and transmits the first physiological components by the following steps Parameter to the mobile device: (a) the mobile device transmits a local time to the detecting unit such that the mobile device synchronizes with the detecting unit in time; (b) the detecting unit transmits the first physiological parameter and corresponds to And a data sequence formed by the plurality of data of the first physiological parameter to the mobile device, wherein the data sequence includes at least one measurement time; and (c) the mobile device stores the data sequence and one of the time corresponding to the measurement UTC. The physiological parameter monitoring system of claim 12, wherein, in the step (c), the mobile device sorts the first physiological parameters according to the world standard time.